These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30140252)

  • 1. Myotonic Dystrophy-A Progeroid Disease?
    Meinke P; Hintze S; Limmer S; Schoser B
    Front Neurol; 2018; 9():601. PubMed ID: 30140252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle wasting in myotonic dystrophies: a model of premature aging.
    Mateos-Aierdi AJ; Goicoechea M; Aiastui A; Fernández-Torrón R; Garcia-Puga M; Matheu A; López de Munain A
    Front Aging Neurosci; 2015; 7():125. PubMed ID: 26217220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.
    André LM; Ausems CRM; Wansink DG; Wieringa B
    Front Neurol; 2018; 9():368. PubMed ID: 29892259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with myotonic dystrophy, a possible segmental progeroid syndrome, and Duchenne muscular dystrophy have fibroblasts with normal limits for in vitro lifespan and growth characteristics.
    Wertz RL; Hartwig GB; Frost AP; Brophy JJ; Atwater SK; Roses AD
    J Cell Physiol; 1981 May; 107(2):255-60. PubMed ID: 7251683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myotonic dystrophy (DM/Curschmann-Steinert disease) and proximal myotonic myopathy (PROMM/Ricker syndrome). Myotonic muscle diseases with multisystemic manifestations].
    Schneider C; Reiners K; Toyka KV
    Nervenarzt; 2001 Aug; 72(8):618-24. PubMed ID: 11519202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction.
    Renna LV; Cardani R; Botta A; Rossi G; Fossati B; Costa E; Meola G
    Eur J Histochem; 2014 Oct; 58(4):2444. PubMed ID: 25578974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.
    Meola G; Cardani R
    Biochim Biophys Acta; 2015 Apr; 1852(4):594-606. PubMed ID: 24882752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy.
    Ricker K; Koch MC; Lehmann-Horn F; Pongratz D; Speich N; Reiners K; Schneider C; Moxley RT
    Arch Neurol; 1995 Jan; 52(1):25-31. PubMed ID: 7826272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myotonic dystrophy and myotonic dystrophy protein kinase.
    Ueda H; Ohno S; Kobayashi T
    Prog Histochem Cytochem; 2000; 35(3):187-251. PubMed ID: 11064921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of variants in MBNL1 in patients with a myotonic dystrophy-like phenotype.
    Larsen M; Kress W; Schoser B; Hehr U; Müller CR; Rost S
    Eur J Hum Genet; 2016 Oct; 24(10):1467-72. PubMed ID: 27222292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy.
    Winchester CL; Ferrier RK; Sermoni A; Clark BJ; Johnson KJ
    Hum Mol Genet; 1999 Mar; 8(3):481-92. PubMed ID: 9949207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the innate immune response and interferon signalling in myotonic dystrophy type 1 and type 2 cataracts.
    Rhodes JD; Lott MC; Russell SL; Moulton V; Sanderson J; Wormstone IM; Broadway DC
    Hum Mol Genet; 2012 Feb; 21(4):852-62. PubMed ID: 22062891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myotonic dystrophy type 2 and related myotonic disorders.
    Meola G; Moxley RT
    J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA diagnosis in myotonic dystrophy].
    Tachi N
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):3-8. PubMed ID: 8727368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The myotonic dystrophies: molecular, clinical, and therapeutic challenges.
    Udd B; Krahe R
    Lancet Neurol; 2012 Oct; 11(10):891-905. PubMed ID: 22995693
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Bosè F; Renna LV; Fossati B; Arpa G; Labate V; Milani V; Botta A; Micaglio E; Meola G; Cardani R
    Front Neurol; 2019; 10():992. PubMed ID: 31611837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic mapping of a second myotonic dystrophy locus.
    Ranum LP; Rasmussen PF; Benzow KA; Koob MD; Day JW
    Nat Genet; 1998 Jun; 19(2):196-8. PubMed ID: 9620781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
    Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
    Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Educational and Professional Qualifications of Adults With Myotonic Dystrophies - A Misleading Perception by the Myopathic Face?].
    Stahl K; Wenninger S; Schüller A; Montagnese F; Schoser B
    Fortschr Neurol Psychiatr; 2016 Apr; 84(4):211-6. PubMed ID: 27100845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.